IMVT Immunovant, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$33.62
· of 52w range
· above low
· to high
$15.9552w low
$45.4252w high
Market Cap (MRQ)
$6.93B
P/E
-12.1
EPS
$-2.77
your badges
52W Range
$16–$45
Analyst Rating
STRONG BUY
Price Target
$49
P/E
-12.1
ROE
-73.7%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
IMVT Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$33.62
Market Cap (MRQ)
$6.93B
P/E
-12.1
EPS
$-2.77
ROE
-73.7%
52W Range
$16–$45
IMVT Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-2.772021-03-31 → 2026-03-31
Free Cash Flow$-407M2020-03-31 → 2026-03-31
Net margin·2023-03-31 → 2024-03-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | IMVT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -12.15Y avg ≈-9.1 | ≈-9.1 | · | · | |
| P/S | 351.45Y avg ≈216.0 | ≈216.0 | 102.4 | Overvalued | |
| P/B (MRQ) | 9.45Y avg ≈4.9 | ≈4.9 | 9.0 | Pricier | |
| Price / FCF | -16.85Y avg ≈-11.8 | ≈-11.8 | · | · | |
| Price / Cash Flow | -16.85Y avg ≈-11.8 | ≈-11.8 | · | · | |
| Price / Tangible Book | 8.05Y avg ≈4.9 | ≈4.9 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | IMVT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -58.3%5Y avg ≈-48.7% | ≈-48.7% | -22.4% | Weak | |
| ROE | -73.7%5Y avg ≈-55.6% | ≈-55.6% | -47.3% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | IMVT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 7.35Y avg ≈11.0 | ≈11.0 | 7.9 | Low liquidity | |
| Quick Ratio | 8.65Y avg ≈10.5 | ≈10.5 | 6.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | IMVT | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 229.2% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Beat Rate
25.0%
Avg Surprise
-7.0%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2027 | Aug 12, 2026 | $-0.75 | $-0.63 | -19.5% |
| Dec. 31, 2026 | May 20, 2026 | $-0.73 | $-0.61 | -19.1% |
| June 30, 2026 | $-0.75 | $-0.63 | -19.5% | |
| March 31, 2026 | $-0.73 | $-0.61 | -19.1% | |
| Dec. 31, 2025 | $-0.61 | $-0.73 | 16.3% | |
| Sept. 30, 2025 | $-0.73 | $-0.73 | 0.21% | |
| June 30, 2025 | $-0.71 | $-0.66 | -8.0% | |
| March 31, 2025 | $-0.64 | $-0.73 | 12.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | $102M | $69M | $48M | $26M | |
| SG&A Expense | $76M | $77M | $57M | $48M | $54M | $40M | $18M | $3M | |
| Operating Expenses | $533M | $438M | $283M | $218M | $156M | $108M | $66M | $28M | |
| Interest Expense | · | · | · | · | · | $0 | $625.0K | · | |
| Other Non-op | $2M | $471.0K | $-1M | $-253.0K | $-781.0K | $328.0K | $412.0K | $-155.0K | |
| Pretax Income | $-505M | $-413M | $-259M | $-211M | $-157M | $-108M | $-66M | $-29M | |
| Income Tax | $215.0K | $891.0K | $567.0K | $9.0K | $-84.0K | $-358.0K | $97.0K | $19.0K | |
| Net Income | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | $-29M | |
| EPS (Basic) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| EPS (Diluted) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| Shares (Basic) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · | |
| Shares (Diluted) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · |
Balance Sheet
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $902M | $714M | $635M | $377M | $494M | $400M | $101M | $7M | |
| Receivables | $1M | $2M | $5M | $700.0K | $12M | $596.0K | · | · | |
| Prepaid Expense | $46M | $51M | $25M | $27M | $6M | $8M | $5M | $3M | |
| Current Assets | $949M | $768M | $666M | $404M | $513M | $409M | $109M | $13M | |
| PP&E (Net) | $443.0K | $844.0K | $462.0K | $333.0K | $330.0K | $201.0K | $65.0K | $54.0K | |
| Other Non-current Assets | $8M | $8M | $0 | · | · | · | · | · | |
| Total Assets | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Accounts Payable | $8M | $18M | $7M | $1M | $19M | $2M | $1M | $206.0K | |
| Accrued Liabilities | $97M | $51M | $41M | $40M | $25M | $15M | $11M | $6M | |
| Current Liabilities | $104M | $69M | $49M | $43M | $45M | $19M | $15M | · | |
| Capital Leases | · | · | $0 | $47.0K | $1M | $2M | $0 | · | |
| Total Liabilities | $104M | $69M | $49M | $43M | $46M | $21M | $15M | $6M | |
| Common Stock | $20.0K | $16.0K | $14.0K | $13.0K | $12.0K | $10.0K | $5.0K | $4.0K | |
| Paid-in Capital | $2.60B | $1.95B | $1.44B | $928M | $825M | $590M | $185M | $32M | |
| Retained Earnings | $-1.75B | $-1.24B | $-826M | $-566M | $-355M | $-199M | $-91M | $-25M | |
| AOCI | $730.0K | $1M | $2M | $852.0K | $404.0K | $-298.0K | $-16.0K | $346.0K | |
| Stockholders' Equity | $853M | $707M | $618M | $362M | $470M | $391M | $94M | $7M | |
| Liabilities + Equity | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Shares Outstanding | 203,940,353 | 170,111,593 | 145,582,999 | 130,329,863 | 116,482,899 | 97,971,243 | 54,655,376 | 38,590,381 |
Cash Flow
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $56M | $49M | $41M | $32M | $34M | $19M | $7M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-407M | $-376M | $-214M | $-188M | $-106M | $-83M | $-53M | $-29M | |
| CapEx | $8.0K | $759.0K | $360.0K | $197.0K | $254.0K | $210.0K | $31.0K | $52.0K | |
| Investing Cash Flow | $-8.0K | $-759.0K | $-360.0K | $-197.0K | $-254.0K | $-210.0K | $-31.0K | $-52.0K | |
| Stock Issued | $544M | $450M | $473M | · | · | · | · | $15M | |
| Net Stock Activity | $544M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $596M | $454M | $472M | $71M | $200M | $383M | $147M | $36M | |
| Net Change in Cash | $188M | $79M | $259M | $-117M | $94M | $300M | $94M | $7M | |
| Taxes Paid | $2M | · | $509.0K | $0 | · | · | · | · | |
| Free Cash Flow | $-407M | $-377M | $-215M | $-188M | $-106M | $-84M | $-53M | · | |
| Levered FCF | · | · | · | · | · | $-84M | $-54M | · |
Profitability
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | -1039.5% | -2783.8% | · | · | · | · | |
| Pretax Margin | · | · | -1037.2% | -2783.7% | · | · | · | · | |
| ROA | -58.3% | -57.4% | -48.4% | -45.8% | -33.8% | -41.2% | -107.8% | · | |
| ROE | -73.7% | -78.1% | -40.0% | -54.3% | -32.1% | -26.7% | -64.5% | · |
Liquidity & Solvency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 | 21.8 | · | · | |
| Quick Ratio | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 | 21.3 | · | · |
Efficiency
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | 8.3 | 1.2 | · | · | · | · |
Per Share
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.18 | $4.16 | $4.24 | $2.78 | $4.03 | $4.00 | $1.72 | · | |
| Revenue / Share | · | · | $0.18 | $0.06 | · | · | · | · | |
| Cash Flow / Share | $-2.23 | $-2.48 | $-1.55 | $-1.53 | $-0.97 | · | · | · | |
| Cash / Share | $4.42 | $4.20 | $4.36 | $2.89 | $4.24 | $4.08 | $1.84 | · | |
| EPS (TTM) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · |
Growth Rates
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 229.2% | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $25M | $8M | $0 | · | · | · | |
| Net Income TTM | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | · | |
| Market Cap | $5.07B | $2.91B | $4.70B | $2.02B | $642M | $1.57B | $851M | · | |
| P/E | -9.0 | -6.3 | -17.2 | -9.1 | -3.9 | -13.1 | · | · | |
| P/S | 259.6 | 149.0 | 188.5 | 266.7 | · | · | · | · | |
| P/B | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | 9.0 | · | |
| P / Tangible Book | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | · | · | |
| P / Cash Flow | -12.4 | -7.7 | -22.0 | -10.7 | -6.0 | -18.9 | -15.9 | · | |
| P / FCF | -12.4 | -7.7 | -21.9 | -10.7 | -6.0 | -18.8 | -15.9 | · | |
| Earnings Yield | -11.2% | -16.0% | -5.8% | -11.0% | -25.9% | -7.6% | · | · |
Income Statement
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $28M | |
| SG&A Expense | $18M | $17M | $15M | $18M | $26M | $20M | $20M | $18M | $19M | $15M | $13M | $14M | $15M | $12M | $12M | $12M | |
| Operating Expenses | $160M | $160M | $114M | $132M | $127M | $114M | $114M | $116M | $94M | $81M | $62M | $62M | $78M | $64M | $50M | $40M | |
| Other Non-op | $4.0K | $798.0K | $-54.0K | $250.0K | $1M | $1M | $-1M | $629.0K | $28.0K | $-3M | $1M | $20.0K | $464.0K | $-2M | $793.0K | $354.0K | |
| Pretax Income | $-153M | $-151M | $-109M | $-126M | $-120M | $-106M | $-111M | $-109M | $-87M | $-75M | $-52M | $-58M | $-74M | $-63M | $-48M | $-40M | |
| Income Tax | $0 | $-3M | $2M | $594.0K | $913.0K | $584.0K | $152.0K | $78.0K | $77.0K | $232.0K | $-108.0K | $454.0K | $-11.0K | $387.0K | $261.0K | $352.0K | |
| Net Income | $-153M | $-148M | $-111M | $-127M | $-121M | $-106M | $-111M | $-109M | $-87M | $-75M | $-51M | $-59M | $-74M | $-63M | $-48M | $-40M | |
| EPS (Basic) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| EPS (Diluted) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| Shares (Basic) | 205,545,373 | · | 181,513,386 | 173,643,829 | 170,872,994 | · | 146,922,338 | 146,468,991 | 146,085,729 | · | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 | |
| Shares (Diluted) | 205,545,373 | · | 181,513,386 | 173,643,829 | 170,872,994 | · | 146,922,338 | 146,468,991 | 146,085,729 | · | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 |
Balance Sheet
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $798M | $902M | $995M | $522M | $599M | $714M | $375M | $473M | $560M | $635M | $691M | $270M | $330M | $433M | $406M | $427M | |
| Receivables | $697.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $1M | $1M | $823.0K | $704.0K | $4M | $13M | |
| Prepaid Expense | $53M | $43M | $47M | $50M | $51M | $51M | $36M | $33M | $27M | $25M | $19M | $20M | $19M | $21M | $17M | $16M | |
| Current Assets | $851M | $949M | $1.04B | $574M | $652M | $768M | $413M | $507M | $589M | $666M | $711M | $291M | $350M | $454M | $426M | $456M | |
| PP&E (Net) | $351.0K | $443.0K | $531.0K | $632.0K | $737.0K | $844.0K | $752.0K | $671.0K | $565.0K | $462.0K | $376.0K | $304.0K | $325.0K | $362.0K | $312.0K | $328.0K | |
| Other Non-current Assets | $961.0K | $8M | $9M | $9M | $9M | $8M | $8M | $8M | · | $0 | · | · | · | · | · | · | |
| Total Assets | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Accounts Payable | $10M | $8M | $9M | $7M | $8M | $18M | $20M | $21M | $11M | $7M | $4M | $8M | $26M | $14M | $7M | $1M | |
| Accrued Liabilities | · | $97M | · | · | · | $51M | $48M | $46M | $34M | $41M | $28M | $32M | $24M | $26M | $23M | $19M | |
| Current Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $41M | $32M | $21M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $306.0K | $614.0K | $919.0K | |
| Total Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $42M | $32M | $22M | |
| Common Stock | $20.0K | $20.0K | $20.0K | $17.0K | $16.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | |
| Paid-in Capital | $2.63B | $2.60B | $2.58B | $2.00B | $1.97B | $1.95B | $1.48B | $1.47B | $1.46B | $1.44B | $1.43B | $950M | $940M | $920M | $841M | $833M | |
| Retained Earnings | $-1.90B | $-1.75B | $-1.60B | $-1.49B | $-1.36B | $-1.24B | $-1.13B | $-1.02B | $-913M | $-826M | $-750M | $-699M | $-640M | $-507M | $-444M | $-396M | |
| AOCI | $725.0K | $730.0K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $-600.0K | $513.0K | $582.0K | $1M | $-1M | $-263.0K | |
| Stockholders' Equity | $735M | $853M | $986M | $520M | $609M | $707M | $353M | $449M | $545M | $618M | $679M | $252M | $300M | $415M | $396M | $436M | |
| Liabilities + Equity | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Shares Outstanding | 206,264,878 | 203,940,353 | 203,316,885 | 174,532,710 | 171,069,176 | 170,111,593 | 147,203,565 | 146,565,049 | 146,195,673 | 145,582,999 | 145,094,052 | 131,442,024 | 130,565,429 | 129,260,254 | 116,614,088 | 116,524,158 |
Cash Flow
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $11M | $13M | $13M | $19M | $12M | $12M | $13M | $13M | $10M | $10M | $11M | $11M | $9M | $8M | $8M | |
| Operating Cash Flow | $-124M | $-95M | $-92M | $-103M | $-117M | $-111M | $-100M | $-89M | $-76M | $-60M | $-47M | $-60M | $-47M | $-46M | $-20M | $-66M | |
| CapEx | · | $8.0K | $0 | $0 | $0 | $201.0K | $180.0K | $196.0K | $182.0K | $150.0K | $131.0K | $34.0K | $45.0K | $98.0K | $31.0K | $42.0K | |
| Investing Cash Flow | · | $-8.0K | $0 | $0 | $0 | $-201.0K | $-180.0K | $-196.0K | $-182.0K | $-150.0K | $-131.0K | $-34.0K | $-45.0K | $-98.0K | $-31.0K | $-42.0K | |
| Stock Issued | · | $0 | · | · | · | $450M | · | · | · | · | · | · | · | $70M | · | · | |
| Financing Cash Flow | $20M | $4M | $565M | $25M | $3M | $451M | $2M | $730.0K | $686.0K | $2M | $470M | $148.0K | $890.0K | $71M | $0 | $21.0K | |
| Net Change in Cash | $-104M | $-92M | $473M | $-77M | $-115M | $339M | $-98M | $-87M | $-75M | $-56M | $421M | $-60M | $-47M | $27M | $-21M | $-67M | |
| Free Cash Flow | · | · | · | · | $-117M | · | · | · | $-76M | · | · | · | $-47M | · | · | $-66M |
Profitability
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | · | · | · | · | · | · | · | · | -575.6% | -1642.3% | -1818.9% | -2147.7% | -4153.2% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -576.8% | -1629.6% | -1819.1% | -2134.5% | -4130.6% | · | |
| ROA | -20.2% | · | -15.0% | -23.0% | -19.3% | · | -19.6% | -27.0% | -18.5% | · | -8.8% | -16.3% | -18.3% | -12.7% | -9.6% | -9.5% | |
| ROE | -22.8% | · | -16.5% | -26.1% | -20.9% | · | -21.5% | -31.1% | -20.6% | · | -9.4% | -18.1% | -20.1% | -13.8% | -10.3% | -10.1% |
Liquidity & Solvency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | · | 15.7 | 9.1 | 12.3 | · | 6.0 | 7.6 | 13.1 | · | 22.1 | 7.2 | 6.8 | 11.0 | 13.4 | 21.5 | |
| Quick Ratio | 6.8 | · | 15.0 | 8.3 | 11.4 | · | 5.5 | 7.1 | 12.5 | · | 21.6 | 6.7 | 6.4 | 10.5 | 12.9 | 20.7 |
Efficiency
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | 10.3 | 1.4 | 0.6 | 8.4 | 0.6 | · |
Per Share
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.57 | · | $4.85 | $2.98 | $3.56 | · | $2.40 | $3.06 | $3.73 | · | $4.68 | $1.92 | $2.30 | $3.21 | $3.39 | $3.75 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | $0.06 | $0.03 | $0.03 | $0.02 | $0.01 | · | |
| Cash Flow / Share | $-0.61 | · | · | · | $-0.69 | · | · | · | $-0.52 | · | · | · | $-0.36 | · | · | $-0.56 | |
| Cash / Share | $3.87 | · | $4.89 | $2.99 | $3.50 | · | $2.55 | $3.23 | $3.83 | · | $4.76 | $2.05 | $2.53 | $3.35 | $3.48 | $3.67 | |
| EPS (TTM) | $-2.81 | · | $-2.68 | $-2.83 | $-2.84 | · | $-2.60 | $-2.20 | $-1.91 | · | $-1.84 | $-1.97 | $-1.93 | $-1.66 | $-1.53 | $-1.47 |
Valuation (TTM)
| Metric | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | $1M | $0 | |
| Net Income TTM | $-538M | · | $-464M | $-465M | $-447M | · | $-383M | $-323M | $-273M | · | $-243M | $-255M | $-245M | $-199M | $-177M | $-167M | |
| Market Cap | $7.95B | · | $5.17B | $2.81B | $2.74B | · | $3.65B | $4.18B | $3.86B | · | $6.11B | $5.05B | $2.48B | $2.29B | $651M | $454M | |
| P/E | -13.7 | · | -9.5 | -5.7 | -5.6 | · | -9.5 | -13.0 | -13.8 | · | -22.9 | -19.5 | -9.8 | -10.7 | -3.6 | -2.7 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | 559.9 | 563.9 | · | |
| P/B | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Tangible Book | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Cash Flow | -63.9 | · | · | · | -23.3 | · | · | · | -50.7 | · | · | · | -52.3 | · | · | -6.9 | |
| Earnings Yield | -7.3% | · | -10.5% | -17.6% | -17.8% | · | -10.5% | -7.7% | -7.2% | · | -4.4% | -5.1% | -10.2% | -9.3% | -27.4% | -37.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Net Income | $-506M | $-414M | $-259M | $-211M | $-157M |
| Diluted EPS | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Current Ratio | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 |
| Quick Ratio | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 |
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-407M | $-377M | $-215M | $-188M | $-106M |
Institutional owners (13F) 246 filers · $4.4B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
246
Value held
$4.4B
New positions
41
Exited positions
21
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 41 (-8 vs prior Q) | 21 (-2 vs prior Q) | 75 (-19 vs prior Q) | 81 (+37 vs prior Q) | +645K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $623,664,634 | 16,186,469 | 14.33% | Shares |
| Deep Track Capital, LP | $359,914,548 | 9,341,151 | 8.27% | Shares |
| BlackRock, Inc. | $276,679,973 | 7,180,897 | 6.36% | Shares |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $223,666,650 | 5,805,000 | 5.14% | Shares |
| BAKER BROS. ADVISORS LP | $209,419,027 | 5,435,220 | 4.81% | Shares |
| VANGUARD GROUP INC | $197,750,162 | 7,779,314 | 4.54% | Shares |
| STATE STREET CORP | $177,893,203 | 4,617,005 | 4.09% | Shares |
| MORGAN STANLEY | $174,727,164 | 4,534,833 | 4.01% | Shares |
| TCG Crossover Management, LLC | $171,766,278 | 4,457,988 | 3.95% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $150,671,912 | 3,910,509 | 3.46% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $140,198,379 | 3,638,681 | 3.22% | Shares |
| JENNISON ASSOCIATES LLC | $127,543,468 | 3,310,238 | 2.93% | Shares |
| RTW INVESTMENTS, LP | $122,442,522 | 3,177,849 | 2.81% | Shares |
| Two Seas Capital LP | $121,311,898 | 3,148,505 | 2.79% | Shares |
| ADAR1 Capital Management, LLC | $89,802,487 | 2,330,716 | 2.06% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $86,115,373 | 2,234,602 | 1.98% | Shares |
| Woodline Partners LP | $76,130,233 | 1,975,869 | 1.75% | Shares |
| GOLDMAN SACHS GROUP INC | $67,473,081 | 1,751,183 | 1.55% | Shares |
| ARMISTICE CAPITAL, LLC | $66,888,080 | 1,736,000 | 1.54% | Shares |
| Alpine Global Management, LLC | $52,978,748 | 1,375,000 | 1.22% | Shares |
| PERCEPTIVE ADVISORS LLC | $52,299,967 | 1,357,383 | 1.20% | Shares |
| D. E. Shaw & Co., Inc. | $47,802,399 | 1,240,654 | 1.10% | Shares |
| ARMISTICE CAPITAL, LLC | $46,236,000 | 1,200,000 | 1.06% | Call option |
| BANK OF AMERICA CORP /DE/ | $45,521,345 | 1,181,452 | 1.05% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39,397,426 | 1,022,513 | 0.90% | Shares |
| Aberdeen Group plc | $33,021,366 | 857,030 | 0.76% | Shares |
| NORTHERN TRUST CORP | $30,592,975 | 794,004 | 0.70% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $28,003,604 | 726,800 | 0.64% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26,223,210 | 680,592 | 0.60% | Shares |
| Logos Global Management LP | $25,622,450 | 665,000 | 0.59% | Shares |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23,853,769 | 619,096 | 0.55% | Shares |
| Nuveen, LLC | $23,196,833 | 602,046 | 0.53% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $21,740,398 | 564,246 | 0.50% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $18,262,604 | 473,984 | 0.42% | Shares |
| UBS Group AG | $18,190,861 | 472,122 | 0.42% | Shares |
| Pictet Asset Management Holding SA | $17,814,692 | 462,359 | 0.41% | Shares |
| MILLENNIUM MANAGEMENT LLC | $12,663,963 | 328,678 | 0.29% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $12,332,336 | 320,071 | 0.28% | Shares |
| JANE STREET GROUP, LLC | $11,959,712 | 310,400 | 0.27% | Call option |
| Bank of New York Mellon Corp | $11,396,826 | 295,791 | 0.26% | Shares |
| HighVista Strategies LLC | $10,706,447 | 277,873 | 0.25% | Shares |
| STEMPOINT CAPITAL LP | $10,654,585 | 276,527 | 0.24% | Shares |
| Tetragon Partners GP Ltd | $9,861,137 | 255,934 | 0.23% | Shares |
| Soleus Capital Management, L.P. | $9,709,560 | 252,000 | 0.22% | Shares |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8,028,419 | 208,368 | 0.18% | Shares |
| Granahan Investment Management, LLC | $7,951,513 | 206,372 | 0.18% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7,050,990 | 183,000 | 0.16% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6,288,096 | 163,200 | 0.14% | Put option |
| CITADEL ADVISORS LLC | $6,169,539 | 160,123 | 0.14% | Shares |
| ALGERT GLOBAL LLC | $6,158,635 | 159,840 | 0.14% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. ×11 filings | Dec. 12, 2025 | 55.90% | Amendment | · | SEC |
| Roderick Wong, M.D. | Dec. 27, 2019 | · | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 27 insiders · 17 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Eric Venker | Chief Executive Officer | July 1, 2026 M | 254,280 | 0 | 3 | $-461,834 |
| Peter Salzmann | Chief Executive Officer | April 16, 2025 S | 1,178,191 | 0 | 0 | $0 |
| Roderick Wong, M.D. | Chief Executive Officer | Dec. 11, 2019 P | 902,498 | 0 | 0 | $0 |
| Tiago Girao | Chief Financial Officer | July 23, 2026 S | 240,798 | 0 | 3 | $-1,410,626 |
| Eva Renee Barnett | Chief Financial Officer | April 16, 2025 S | 396,774 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | Chief Financial Officer | March 19, 2021 A | 46,200 | 0 | 0 | $0 |
| Melanie Gloria | Chief Operating Officer | Aug. 20, 2026 S | 219,301 | 0 | 14 | $-1,600,150 |
| Christopher Van Tuyl | Chief Legal Officer | Sept. 23, 2026 S | 176,545 | 0 | 10 | $-1,418,316 |
| Jay S Stout | Chief Technology Officer | July 23, 2026 S | 205,341 | 0 | 15 | $-2,271,089 |
| Michael Geffner | Chief Medical Officer | Oct. 22, 2025 S | 217,958 | 0 | 2 | $-70,117 |
| William L. Macias | Chief Medical Officer | Feb. 19, 2025 S | 357,353 | 0 | 0 | $0 |
| Mark S. Levine | Chief Legal Officer | Nov. 20, 2024 S | 319,228 | 0 | 0 | $0 |
| Julia G. Butchko | Chief Development Officer | Aug. 21, 2024 S | 440,959 | 0 | 0 | $0 |
| Michael James Elliott | Chief Scientific Officer | March 19, 2021 A | 97,600 | 0 | 0 | $0 |
| Rita Jain | Chief Medical Officer | March 19, 2021 A | 129,365 | 0 | 0 | $0 |
| Bradford W Middlekauff | General Counsel | May 15, 2020 A | · | 0 | 0 | $0 |
| Robert K Zeldin | Chief Medical Officer | Dec. 18, 2019 A | · | 0 | 0 | $0 |
| Atul Pande | Director | Aug. 28, 2026 M | 116,731 | 0 | 5 | $-424,650 |
| Andrew J. Fromkin | Director | May 28, 2026 M | 74,382 | 0 | 4 | $-7,955,300 |
| Robert Graham Susman | Director | May 1, 2026 S | 36,394 | 0 | 1 | $-67,979 |
| Douglas J. Hughes | Director | April 7, 2026 A | 134,653 | 0 | 2 | $-348,666 |
| Jake Bauer | Director | April 7, 2026 A | 38,896 | 0 | 0 | $0 |
| Frank Torti | Director | April 7, 2026 A | 1,009,228 | 0 | 0 | $0 |
| Roivant Sciences Ltd. | Director | Dec. 12, 2025 P | 113,317,007 | 1 | 0 | $349,999,986 |
| George V Migausky | Director | April 1, 2025 A | 137,251 | 0 | 0 | $0 |
| Myrtle S Potter | Director | Dec. 18, 2019 A | · | 0 | 0 | $0 |
| Health Sciences Holdings, LLC | 10% owner | Dec. 18, 2019 J | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 33 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| GURU · Global X Funds | 1.59% | 25,151 NS | July 31, 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0.77% | 9,245 NS | July 31, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.68% | 87,318 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.47% | 14,619 SH | Oct. 2, 2026 | Daily |
| ESSC · Strategy Shares | 0.34% | 3,180 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.23% | 618,035 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.21% | 801,227 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.19% | 1,193 NS | July 31, 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 91,474 SH | Aug. 19, 2026 | Daily |
| BKSE · BNY Mellon ETF Trust | 0.14% | 3,097 NS | July 31, 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.13% | 23,292 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.11% | 27,234 SH | Sept. 11, 2026 | Daily |
| IWM · iShares Trust | 0.11% | 2,184,173 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.11% | 40,851 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 490,917 SH | Aug. 19, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 1,086,290 SH | Aug. 19, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | 0.05% | 28,526 SH | Aug. 19, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.04% | 1,883,385 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.04% | 199,146 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 30,567 SH | Oct. 2, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 31,435 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 887,661 SH | Aug. 19, 2026 | Daily |
| WSML · iShares Trust | 0.02% | 4,355 SH | Sept. 11, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.01% | 18,937 SH | Aug. 19, 2026 | Daily |
| ITOT · iShares Trust | 0.00% | 116,576 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 24,022 SH | Sept. 10, 2026 | Daily |
| TILT · FlexShares Trust | 0.00% | 2,430 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,600,899 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 67,319 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,098 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 18 NS | July 31, 2026 | N-PORT |
| ISCB · iShares Trust | · | 3,864 SH | Sept. 11, 2026 | Daily |
| SMLF · iShares Trust | · | 16,335 SH | Sept. 11, 2026 | Daily |
IMVT Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 23 analysts
BUY
Median target
$48.50
+44.3%
9 39.1%
Strong Buy
9 39.1%
Buy
5 21.7%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
16 analysts · 2026-09-28Mean target $48.88 +45.4%
Now
Current price $33.62
Low$30.00
Mean$48.88
High$66.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| IMVT | $5.07B | -9.0 | 229.2% | · | -73.7% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
| IONS | $12.92B | -33.2 | · | · | -68.1% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026